iScience (May 2023)

Pancreas-derived DPP4 is not essential for glucose homeostasis under metabolic stress

  • Evgenia Fadzeyeva,
  • Cassandra A.A. Locatelli,
  • Natasha A. Trzaskalski,
  • My-Anh Nguyen,
  • Megan E. Capozzi,
  • Branka Vulesevic,
  • Nadya M. Morrow,
  • Peyman Ghorbani,
  • Antonio A. Hanson,
  • Ilka Lorenzen-Schmidt,
  • Mary-Anne Doyle,
  • Richard Seymour,
  • Elodie M. Varin,
  • Morgan D. Fullerton,
  • Jonathan E. Campbell,
  • Erin E. Mulvihill

Journal volume & issue
Vol. 26, no. 5
p. 106748

Abstract

Read online

Summary: Mice systemically lacking dipeptidyl peptidase-4 (DPP4) have improved islet health, glucoregulation, and reduced obesity with high-fat diet (HFD) feeding compared to wild-type mice. Some, but not all, of this improvement can be linked to the loss of DPP4 in endothelial cells (ECs), pointing to the contribution of non-EC types. The importance of intra-islet signaling mediated by α to β cell communication is becoming increasingly clear; thus, our objective was to determine if β cell DPP4 regulates insulin secretion and glucose tolerance in HFD-fed mice by regulating the local concentrations of insulinotropic peptides. Using β cell double incretin receptor knockout mice, β cell- and pancreas-specific Dpp4−/− mice, we reveal that β cell incretin receptors are necessary for DPP4 inhibitor effects. However, although β cell DPP4 modestly contributes to high glucose (16.7 mM)-stimulated insulin secretion in isolated islets, it does not regulate whole-body glucose homeostasis.

Keywords